Advertisement
Advertisement

ANIX

ANIX logo

Anixa Biosciences, Inc.

3.04
USD
Sponsored
-0.06
-1.77%
Jan 30, 15:20 UTC -5
Closed
exchange

After-Market

3.11

+0.07
+2.27%

ANIX Earnings Reports

Positive Surprise Ratio

ANIX beat 20 of 29 last estimates.

69%

Next Report

Date of Next Report
Mar 09, 2026
Estimate for Q1 26 (Revenue/ EPS)
--
/
-$0.09
Implied change from Q4 25 (Revenue/ EPS)
--
/
--
Implied change from Q1 25 (Revenue/ EPS)
--
/
-10.00%

Anixa Biosciences, Inc. earnings per share and revenue

On Jan 12, 2026, ANIX reported earnings of -0.09 USD per share (EPS) for Q4 25, missing the estimate of -0.08 USD, resulting in a -0.78% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -1.17% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 5 analysts forecast an EPS of -0.09 USD, with revenue projected to reach -- USD, implying an increase of 0.00% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
FAQ
For Q4 2025, Anixa Biosciences, Inc. reported EPS of -$0.09, missing estimates by -0.78%, and revenue of $0.00, 0% as expectations.
The stock price moved down -1.17%, changed from $3.42 before the earnings release to $3.38 the day after.
The next earning report is scheduled for Mar 09, 2026.
Based on 5 analysts, Anixa Biosciences, Inc. is expected to report EPS of -$0.09 and revenue of -- for Q1 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement